CYCLOSPORINE AND METHOTREXATE VERSUS CYCLOSPORINE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN HLA-IDENTICAL SIBLING FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Mekni, Sabrine [1 ]
Ben Abdeljelil, Nour [1 ]
Ladeb, Saloua [1 ]
Kanoun, Rimmel Yosra [1 ]
Ben Yaiche, Insaf [1 ]
Ouerghi, Rihab [1 ]
Torjemane, Lamia [1 ]
Turki, Ines [1 ]
Belloumi, Dorra [1 ]
Ben Othman, Tarek [1 ]
机构：
[1] Ctr Natl Greffe Moelle Osseuse, Tunis, Tunisia
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P247
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [31] GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH METHOTREXATE CYCLOSPORINE IN CHILDREN WITH SEVERE APLASTIC-ANEMIA TREATED WITH CYCLOPHOSPHAMIDE AND HLA-IDENTICAL MARROW GRAFTS
    STORB, R
    SANDERS, JE
    PEPE, M
    ANASETTI, C
    APPELBAUM, FR
    BUCKNER, CD
    DEEG, HJ
    DONEY, K
    HANSEN, J
    MARTIN, P
    STEWART, P
    SULLIVAN, KM
    THOMAS, ED
    WITHERSPOON, RP
    BLOOD, 1991, 78 (04) : 1144 - 1145
  • [32] Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: long-term follow-up of a randomized study
    Ruutu, T
    Volin, L
    Juvonen, E
    Parkkali, T
    Elonen, E
    Nihtinen, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S138 - S138
  • [33] Long-Term Follow-up of a Randomized Trial Comparing Cyclosporine and Short Course Methotrexate with Cyclosporine and Mycophenolate Mofetil for Graft Versus Host Disease Prophylaxis in Myeloablative HLA-Identical Sibling Hematopoietic Cell Transplantation.
    Hamilton, Betty K.
    Bolwell, Brian J.
    Kalaycio, Matt
    Rybicki, Lisa
    Hanna, Rabi
    Sobecks, Ronald
    Pohlman, Brad
    Andresen, Steven
    Dean, Robert M.
    Duong, Hien K.
    Hill, Brian T.
    Copelan, Edward A.
    BLOOD, 2012, 120 (21)
  • [34] Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Li, Jian-Ming
    Giver, Cynthia R.
    Lu, Ying
    Hossain, Mohammad S.
    Akhtari, Mojtaba
    Waller, Edmund K.
    IMMUNOTHERAPY, 2009, 1 (04) : 599 - 621
  • [35] METHOTREXATE AND CYCLOSPORINE COMPARED WITH CYCLOSPORINE ALONE FOR PROPHYLAXIS OF ACUTE GRAFT VERSUS HOST-DISEASE AFTER MARROW TRANSPLANTATION FOR LEUKEMIA
    STORB, R
    DEEG, HJ
    WHITEHEAD, J
    APPELBAUM, F
    BEATTY, P
    BENSINGER, W
    BUCKNER, CD
    CLIFT, R
    DONEY, K
    FAREWELL, V
    HANSEN, J
    HILL, R
    LUM, L
    MARTIN, P
    MCGUFFIN, R
    SANDERS, J
    STEWART, P
    SULLIVAN, K
    WITHERSPOON, R
    YEE, G
    THOMAS, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (12): : 729 - 735
  • [36] CYCLOSPORINE AND METHYLPREDNISOLONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
    SHEPHERD, JD
    SHORE, TB
    REECE, DE
    BARNETT, MJ
    KLINGEMANN, HG
    BUSKARD, NA
    PHILLIPS, GL
    BONE MARROW TRANSPLANTATION, 1988, 3 (06) : 553 - 558
  • [37] Impact of TNFRSF5 polymorphism on chronic graft-versus-host disease in HLA-identical sibling hematopoietic stem cell transplantation outcome
    Loiseau, Pascale
    Busson, Marc
    Dourche, Monique
    Rocha, Vanderson
    Socie, Gerard
    Toubert, Antoine
    Charron, Dominique
    TISSUE ANTIGENS, 2010, 75 (05): : 557 - 558
  • [38] ACUTE GRAFT-VERSUS-HOST DISEASE - ANALYSIS OF RISK-FACTORS AFTER ALLOGENEIC MARROW TRANSPLANTATION AND PROPHYLAXIS WITH CYCLOSPORINE AND METHOTREXATE
    NASH, RA
    PEPE, MS
    STORB, R
    LONGTON, G
    PETTINGER, M
    ANASETTI, C
    APPELBAUM, FR
    BOWDEN, RA
    DEEG, HJ
    DONEY, K
    MARTIN, PJ
    SULLIVAN, KM
    SANDERS, J
    WITHERSPOON, RP
    BLOOD, 1992, 80 (07) : 1838 - 1845
  • [39] Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
    Yanada, M
    Emi, N
    Naoe, T
    Sakamaki, H
    Takahashi, S
    Hirabayashi, N
    Hiraoka, A
    Kanda, Y
    Tanosaki, R
    Okamoto, S
    Iwato, K
    Atsuta, Y
    Hamajima, N
    Tanimoto, M
    Kato, S
    BONE MARROW TRANSPLANTATION, 2004, 34 (04) : 331 - 337
  • [40] Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
    M Yanada
    N Emi
    T Naoe
    H Sakamaki
    S Takahashi
    N Hirabayashi
    A Hiraoka
    Y Kanda
    R Tanosaki
    S Okamoto
    K Iwato
    Y Atsuta
    N Hamajima
    M Tanimoto
    S Kato
    Bone Marrow Transplantation, 2004, 34 : 331 - 337
12345